OJN  Vol.2 No.2 , June 2012
Screening for cervical neoplasia in a health center in Western Andalusia
Abstract: We have analyzed the annual burden of 736 smears collected in the screening of cervical neoplasia at primary care facility where we work. We could not detect any neoplasia. Of the 50 positive smears (6.79% of total), 4 cases showed HSIL (high grade intraepithelial lesion) (median age 32 years) and 10 cases had LSIL (low grade intraepithelial lesion) (median age 25.5 years). The median age of the 733 satisfactory smears was 40 years. Age was a significant predictor for having an altered cytology (OR = 0.96, 95% CI = 0.93 to 0.98, p = 0.001190). Candida albicans was the microorganism more frequently associated with non- neoplastic inflammatory changes.
Cite this paper: Duclós-García, C. , Pareja-Arcos, C. and Ortega-Calvo, M. (2012) Screening for cervical neoplasia in a health center in Western Andalusia. Open Journal of Nursing, 2, 36-40. doi: 10.4236/ojn.2012.22007.

[1]   Vioque, J. and Fenollar, J. (1995) The distribution of cervical cancer mortality in Spain (1981-1986). An ecological study. Medicina Clínica, 104, 287-292.

[2]   Llorca, J., Prieto, M.D. and Delgado-Rodríguez, M. (1999) Increase in cervical cancer mortality in Spain, 1951-1991. Journal of Epidemiology & Community Health, 53, 408-411. doi:10.1136/jech.53.7.408

[3]   Rodríguez-Rieiro, C., Aragonés, N., Pollan, M., López-Abente, G. and Pérez-Gómez, B. (2009) Temporal trends of cervical cancer mortality rates among regions in Spain: 1975-2004. Medicina Clínica, 133, 41-46.

[4]   Llorca, J., Rodriguez-Cundin, P., Dierssen-Sotos, T. and Prieto-Salceda, D. (2006) Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Letters, 240, 36-40. doi:10.1016/j.canlet.2005.08.021

[5]   Puig-Tintoré, L.M., Castellsagué, X., Torné, A., De Sanjosé, S., Cortés, J., Roura, E., Méndez, C. and Bosch, F.X. (2008) Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: A population-based survey in Spain. Journal of Lower Genital Tract Disease, 12, 82-89.

[6]   Ortega Calvo, M., Martínez Manzanares, C., Manzanares Torné, M.L., Pérez Torres, I., Sánchez Bursón, J.M., López Montes, M. and Pino Mejías, R. (1987) Epidemiología Analítica del Cérvix Neoplásico en el sur de Espa?a. Revista Clínica Espa?ola, 181, 534-538.

[7]   De Sanjose, S., Quint, W.G., et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncology, 11, 1048-1056. doi:10.1016/S1470-2045(10)70230-8

[8]   Franceschi, S., Plummer, M., et al. (2009) Differences in the risk of cervical cancer and human papillomavirus infection by education level. British Journal of Cancer, 101, 865-870. doi:10.1038/sj.bjc.6605224

[9]   Bosch, F.X. and De Sanjosé, S. (2007) The epidemiology of human papillomavirus infection and cervical cancer. Disease Markers, 23, 213-227.

[10]   Márquez Calderón, S. (2008) The human papilloma virus vaccine: reflections on the dissemination process, scientific evidence and doubts. Enfermería Clínica, 18, 55-58.

[11]   Márquez Calderón, S., Lopez-Valcarcel, B.G. and Segura, A. (2009) Medical societies’ recommendations for immunization with Human Papillomavirus vaccine and disclosure of conflicts of interests. Preventive Medicine, 48, 449-453. doi:10.1016/j.ypmed.2009.02.018

[12]   Mody, D.R., Nayar, R. and Thrall, M. (2011) Bethesda System classification of glandular lesions on cervical cytology. Monographs in Clinical Cytology, 20, 5-14.

[13]   Ihaka, R. and Gentleman, R.R. (1996) A language for data analysis and graphics. Journal of Computational and Graphical Statistics, 5, 299-314.

[14]   Ortega Calvo, M. and Cayuela Domínguez, A. (2002) Regresión logística no condicionada y tama?o de muestra: una revisión bibliográfica. Revista Espa?ola de Salud Pública, 76, 85-93.

[15]   Oncins, R., Fuente, C. and Nájar, M. (2001) Estudio descriptivo de los casos de neoplasia intraepitelial grado III (CIN III) en el área del Hospital de Barbastro. Atención Primaria, 28, 457-462.

[16]   Nicodemus, K.K. (2008) Catmap: Case-control and TDT meta-analysis package. BMC Bioinformatics, 9, 130. doi:10.1186/1471-2105-9-130

[17]   Cáceres, A., Armengol, L., Villatoro, S. and González, J.R. (2011) MLPAstats: An R GUI package for the integrated analysis of copy number alterations using MLPA data. BMC Bioinformatics, 12, 147. doi:10.1186/1471-2105-12-147

[18]   Oca?a-Riola, R., Sánchez-Cantalejo, C., Rosell, J., Sánchez-Cantalejo, E. and Daponte, A. (2004) Socio-economic level, farming activities and risk of cancer in small areas of Southern Spain. European Journal of Epidemiology, 19, 643-650. doi:10.1023/B:EJEP.0000036808.26094.43

[19]   Loomis, D.M., Pastore, P.A., Rejman, K., Gutierrez, K.L. and Bethea, B. (2009) Cervical cytology in vulnerable pregnant women. Journal of the American Academy of Nurse Practitioners, 21, 287-294.

[20]   Lamont, R.F., Sobel, J.D., Akins, R.A., Hassan, S.S., Chaiworapongsa, T., Kusanovic, J.P. and Romero, R. (2011) The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG: An International Journal of Obstetrics and Gynaecology, 118, 533-549.

[21]   Merki-Feld, G.S., Rosselli, M. and Imthurn, B. (2008) Comparison of two procedures for routine IUD exchange in women with positive pap smears for actinomyces-like organisms. Contraception, 77, 177-180. doi:10.1016/j.contraception.2007.11.007

[22]   Wiesner-Ceballos, C., Murillo Moreno, R.H., Pi?eros Petersen, M., Tovar-Murillo, S.L., Cendales Duarte, R. and Gutiérrez, M.C. (2009) Control del cáncer cérvicouterino en Colombia: La perspectiva de los actores del sistema de salud. Revista Panamericana de Salud Pública, 25, 1-8. doi:10.1590/S1020-49892009000100001

[23]   Ibrahim, A., Rasch, V., Pukkala, E. and Aro, A.R. (2011) Cervical cancer risk factors and feasibility of visual inspection with acetic acid screening in Sudan. International Journal of Women’s Health, 3, 117-122. doi:10.2147/IJWH.S14189

[24]   Curtis, D. (2011) Patient experience—The ingredient missing from cost-effectiveness calculations. Patient Prefer Adherence, 5, 251-254. doi:10.2147/PPA.S20243

[25]   Fort, V.K., Makin, M.S., Siegler, A.J., Ault, K. and Rochat, R. (2011) Barriers to cervical cancer screening in Mulanje, Malawi: A qualitative study. Patient Prefer Adherence, 5, 125-131.

[26]   álvarez-Soria, M.J., Hernández-González, A., Carrasco-García, De León, S., Del Real-Francia, M.á., Gallardo-Alca?iz, M.J. and López-Gómez, J.L. (2011) Demyelinating disease and vaccination of the human papillomavirus. Revista de Neurología, 52, 472-476.